scholarly journals Optimized expression and purification of adipose triglyceride lipase improved hydrolytic and transacylation activities in vitro

2021 ◽  
Vol 297 (4) ◽  
pp. 101206
Author(s):  
Natalia Kulminskaya ◽  
Claudia Radler ◽  
Roland Viertlmayr ◽  
Christoph Heier ◽  
Peter Hofer ◽  
...  
2007 ◽  
Vol 293 (6) ◽  
pp. E1736-E1745 ◽  
Author(s):  
Erin E. Kershaw ◽  
Michael Schupp ◽  
Hong-Ping Guan ◽  
Noah P. Gardner ◽  
Mitchell A. Lazar ◽  
...  

Peroxisome proliferator-activated receptor-γ (PPARγ) regulates adipocyte genes involved in adipogenesis and lipid metabolism and is the molecular target for thiazolidinedione (TZD) antidiabetic agents. Adipose triglyceride lipase (ATGL) is a recently described triglyceride-specific lipase that is induced during adipogenesis and remains highly expressed in mature adipocytes. This study evaluates the ability of PPARγ to directly regulate ATGL expression in adipocytes in vitro and in vivo. In fully differentiated 3T3-L1 adipocytes, ATGL mRNA and protein are increased by TZD and non-TZD PPARγ agonists in a dose- and time-dependent manner. Rosiglitazone-mediated induction of ATGL mRNA is rapid and is not inhibited by the protein synthesis inhibitor cycloheximide, indicating that intervening protein synthesis is not required for this effect. Rosiglitazone-mediated induction of ATGL mRNA and protein is inhibited by the PPARγ-specific antagonist GW-9662 and is also significantly reduced following siRNA-mediated knockdown of PPARγ, supporting the direct transcriptional regulation of ATGL by PPARγ. In vivo, ATGL mRNA and protein are increased by rosiglitazone treatment in white and brown adipose tissue of mice with and without obesity due to high-fat diet or leptin deficiency. Thus, PPARγ positively regulates ATGL mRNA and protein expression in mature adipocytes in vitro and in adipose tissue in vivo, suggesting a role for ATGL in mediating PPARγ's effects on lipid metabolism.


2020 ◽  
Author(s):  
Beatrix Irene Wieser ◽  
Paola Peña de la Sancha ◽  
Silvia Schauer ◽  
Helga Reicher ◽  
Wolfgang Sattler ◽  
...  

AbstractSterol Regulatory Element-Binding Protein-1c (SREBP-1c) is translated as an inactive precursor-protein that is proteolytically activated to promote fatty-acid (FA) biosynthesis, when unsaturated (u)FAs are scarce. During fasting, however, lipogenesis is low, and adipose-tissue lipolysis supplies the organism with FAs. Adipose TriGlyceride Lipase (ATGL) is the rate-limiting enzyme for lipolysis, and it preferentially hydrolyzes uFAs. Therefore, we hypothesized that ATGL-derived FAs may suppress the proteolytic activation of SREBP-1c in the liver. Here we show that (i) SREBP-1c is inactive during fasting but active after refeeding, (ii) uFA species liberated by ATGL suppress SREBP-1c activation in vitro, (iii) SREBP-1c is hyper-activated in livers of mice lacking ATGL, and (iv) pharmacological inhibition of ATGL selectively activates SREBP-1c in hepatocytes. Our findings highlight an ATGL/SREBP-1c axis, instrumental to coordinate lipogenesis and lipolysis, whose homeostatic regulation is crucial to avoid severe diseases including diabetes, cardiomyopathy, and even cancer.


2009 ◽  
Vol 284 (44) ◽  
pp. 30218-30229 ◽  
Author(s):  
Petra C. Kienesberger ◽  
Daeho Lee ◽  
Thomas Pulinilkunnil ◽  
Daniel S. Brenner ◽  
Lingzhi Cai ◽  
...  

2016 ◽  
Vol 5 (7) ◽  
pp. 527-537 ◽  
Author(s):  
Claire Laurens ◽  
Pierre-Marie Badin ◽  
Katie Louche ◽  
Aline Mairal ◽  
Geneviève Tavernier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document